HB 1223·LA·house
ECONOMIC DEVELOPMENT: Establishes the Louisiana Clinical Trial Competitiveness and Patient Access Act
Signed into LawFiled Mar 31, 2026
Sponsor: Jack McFarland (R)
Latest Action
Signed by the Governor. Becomes Act No. 886.
Jun 9, 2026
Summary
The law establishes the Louisiana Clinical Trial Competitiveness and Patient Access Act to support clinical trial activity and patient access in the state. It adds language that the act cannot require actions prohibited by federal law, and it expands the pricing provision to mention nonpublic protocols. These changes aim to keep state efforts aligned with federal rules while clarifying trial pricing language.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when HB 1223 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1223 freeOr ask your AI assistant about HB 1223 directly:
Add to Claude, ChatGPT or Cursor